Neurofluidic Exoskeletons for Adaptive Gait Rehabilitation: A Translational Perspective

Abstract

Neurofluidic exoskeletons are a revolutionary innovation for gait retraining of individuals with neurological impairments, such as stroke or multiple sclerosis. These fluid-based devices adjust according to patient progress and can provide personalized torque and timing for smoother and more natural movement than traditional, rigid exoskeletons. Recent studies report that exoskeleton-assisted gait training improves gait function and lower limb strength in subacute stroke patients. In contrast, enhanced neuroplasticity appears to arise from the intervention through the use of adaptive control algorithms. However, issues such as device miniaturization, the ease with which devices can be fitted, and equitable access still need to be pondered. Other large-scale studies are needed to establish the long-term effectiveness and cost-benefits. The present commentary argues that the neurofluidic exoskeletons can make a paradigm shift in neurorehabilitation and notes the need for further inquiry and policy mechanisms for integrating these technologies into clinical practice to improve mobility and the quality of life.